A couple of the ARK Invest exchange-traded funds run by ETF star Cathie Wood made huge purchases on Monday. Altogether, these funds bought over 420,000 shares of UiPath Inc. (NYSE: PATH), as the price of these ETFs dropped around 1% on Monday. Note that the funds are still up handily in the past year.
ARK Genomic Revolution ETF (NYSEARCA: ARKG) bought 149,800 shares of UiPath and ARK Innovation ETF (NYSEARCA: ARKK) bought 273,476 shares. At Monday’s closing price, this would have valued these purchases at roughly $28.1 million. Even though this is a small fraction of the total holdings, every little bit counts. ARKG is up about 60% and ARKK is up 57% in the past year.
Check out all of ARK Invest’s buys for Monday:
|ARKQ||KTOS||Kratos Defense & Security Solutions||22,828|
|ARKW||KVSB||Khosla Ventures Acquisition II||110,200|
|ARKW||ZM||Zoom Video Communications||48,400|
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St., owner of 247wallst.com.